LDHA Upregulation Independently Predicts Poor Survival in Lung Adenocarcinoma, but not in Lung Squamous Cell Carcinoma

Tissue-based map of the human proteome

Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286 · see citing works

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

Győrffy, B., Surowiak, P., Budczies, J., & Lánczky, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082241 · Cited by 1,763 · see citing works

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Jagt, D. L. V., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,528 · see citing works

Acidity Generated by the Tumor Microenvironment Drives Local Invasion

Estrella, V. C., Chen, T., Lloyd, M. C., Wojtkowiak, J. W., Cornnell, H. H., Ibrahim‐Hashim, A., Bailey, K. M., Balagurunathan, Y., Rothberg, J. M., Sloane, B. F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2796 · Cited by 1,404 · see citing works

Acid-Mediated Tumor Invasion: a Multidisciplinary Study

Gatenby, R. A., Gawlinski, E. T., Gmitro, A. F., Kaylor, B., & Gillies, R. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4193 · Cited by 771 · see citing works

Disrupting proton dynamics and energy metabolism for cancer therapy

Parks, S. K., Chiche, J., & Pouysségur, J. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3579 · Cited by 613 · see citing works

Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells

Xie, H., Hanai, J.-I., Ren, J.-G., Kats, L., Burgess, K., Bhargava, P., Signoretti, S., Billiard, J., Duffy, K. J., Grant, A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.003 · Cited by 516 · see citing works

Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy

Miao, P., Sheng, S., Sun, X., Liu, J., & Huang, G. (2013) · IUBMB Life · doi:10.1002/iub.1216 · Cited by 425 · see citing works

Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma

Sheng, S. L., Liu, J., Dai, Y., Sun, X. G., Xiong, X. P., & Huang, G. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08748.x · Cited by 263 · see citing works

SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer

Wilbertz, T., Wagner, P. L., Petersen, K., Stiedl, A., Scheble, V. J., Maier, S. H., Reischl, M., Mikut, R., Altorki, N. K., Moch, H., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.49 · Cited by 198 · see citing works

Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells

Rong, Y., Wu, W., Ni, X., Kuang, T., Jin, D., Wang, D., & Lou, W. (2013) · Tumor Biology · doi:10.1007/s13277-013-0679-1 · Cited by 192 · see citing works

Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma

Girgis, H., Masui, O., White, N. M. A., Scorilas, A., Rotondo, F., Seivwright, A., Gabril, M. Y., Filter, E. R., Girgis, A. H., Bjarnason, G. A., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-101 · Cited by 186 · see citing works

Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1)

Shimoji, M., Shimizu, S., Sato, K., Suda, K., Kobayashi, Y., Tomizawa, K., Takemoto, T., & Mitsudomi, T. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.04.021 · Cited by 158 · see citing works

Ion Channels and Transporters in Cancer: Pathophysiology, Regulation, and Clinical Potential

Pedersen, S. F., & Stock, C. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4188 · Cited by 141 · see citing works

High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer

Huang, X., Li, X., Xie, X., Ye, F., Chen, B., Song, C., Tang, H., & Xie, X. (2016) · The Breast · doi:10.1016/j.breast.2016.08.014 · Cited by 140 · see citing works

Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma

Schuurbiers, O. C. J., Meijer, T. W. H., Kaanders, J. H. A. M., Looijen-Salamon, M. G., de Geus‐Oei, L., van der Drift, M. A., van der Heijden, E. H. F. M., Oyen, W. J. G., Visser, E. P., Span, P. N., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000286 · Cited by 132 · see citing works

SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity

Nakatsugawa, M., Takahashi, A., Hirohashi, Y., Torigoe, T., Inoda, S., Murase, M., Asanuma, H., Tamura, Y., Morita, R., Michifuri, Y., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.140 · Cited by 125 · see citing works

Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA

Ooi, A. T., & Gomperts, B. N. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1209 · Cited by 122 · see citing works

A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer

Pértega‐Gomes, N., Vizcaino, J. R., Attig, J., Jurmeister, S., Lopes, C., & Baltazar, F. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-352 · Cited by 119 · see citing works

Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4

Meijer, T. W. H., Schuurbiers, O. C. J., Kaanders, J. H. A. M., Looijen-Salamon, M. G., de Geus‐Oei, L., Verhagen, A. F. T. M., Lok, J., van der Heijden, E. H. F. M., Rademakers, S. E., Span, P. N., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.11.006 · Cited by 118 · see citing works

SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer

Lv, X., Liu, L., Cheng, C., Yu, B., Xiong, L., Hu, K., Tang, J., Zeng, L., & Sang, Y. (2015) · Scientific Reports · doi:10.1038/srep17940 · Cited by 90 · see citing works

Lactate and glycine—potential MR biomarkers of prognosis in estrogen receptor‐positive breast cancers

Giskeødegård, G. F., Lundgren, S., Sitter, B., Fjøsne, H. E., Postma, G., Buydens, L. M. C., Gribbestad, I. S., & Bathen, T. F. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2798 · Cited by 81 · see citing works

The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung.

Karachaliou, N., Rosell, R., & Viteri, S. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.01.01 · Cited by 78 · see citing works

Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters

Koh, Y. W., Lee, S. J., & Park, S. Y. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.12.003 · Cited by 76 · see citing works

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma

Okabe, N., Ezaki, J., Yamaura, T., Muto, S., Osugi, J., Tamura, H., IMAI, J.-I., Ito, E., Yanagisawa, Y., Honma, R., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2817 · Cited by 50 · see citing works

Overexpression of lactate dehydrogenase A in cholangiocarcinoma is correlated with poor prognosis.

Thonsri, U., Seubwai, W., Waraasawapati, S., Sawanyawisuth, K., Vaeteewoottacharn, K., Boonmars, T., & Cha’on, U. (2017) · PubMed · doi:10.14670/hh-11-819 · Cited by 46 · see citing works

Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy

Zhang, J., Wang, H., Lin, Y., Xu, J., Wang, J., Wang, K., & Liu, W. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.11.006 · Cited by 39 · see citing works

A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma

Stewart, P. A., Parapatics, K., Welsh, E. A., Müller, A. C., Cao, H., Fang, B., Koomen, J. M., Eschrich, S. A., Bennett, K. L., & Haura, E. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142162 · Cited by 37 · see citing works

Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis

Zang, X., Chen, M., Zhou, Y., Xiao, G., Xie, Y., & Wang, X. (2015) · Cancer Informatics · doi:10.4137/cin.s17287 · Cited by 30 · see citing works

Upregulation of lactate dehydrogenase a by 14-3-3ζ leads to increased glycolysis critical for breast cancer initiation and progression

Chang, C., Zhang, C., Zhang, Q., Şahin, Ö., Wang, H., Xu, J., Xiao, Y. Q., Zhang, J., Rehman, S. K., Li, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9136 · Cited by 30 · see citing works

The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression

Wei, L., Wang, K., Yang, N., Zhang, L., Li, Z., Li, D., Lei, S., & Hairong, H. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15151486241153 · Cited by 26 · see citing works

Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC)

Schmid‐Bindert, G. (2013) · Targeted Oncology · doi:10.1007/s11523-013-0261-1 · Cited by 18 · see citing works

Interactive Human Protein Atlas Launches

(2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-nb2015-019 · Cited by 12 · see citing works

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma

Hou, X., Shi, X., Zhang, W., Li, D., Hu, L., Yang, J., Zhao, J., Wei, S., Wei, X., Ruan, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03641-8 · Cited by 98 · see citing works

High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients

Xie, L., Dang, Y., Guo, J. J., Sun, X., Xie, T., Zhang, L., Yan, Z., Amin, H., & Guo, X. (2019) · Genes · doi:10.3390/genes10010036 · Cited by 68 · see citing works

Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities

Jain, A., & Bhardwaj, V. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i39.6527 · Cited by 59 · see citing works

Structural and Functional Regulation of Lactate dehydrogenase-A in Cancer

Woodford, M. R., Chen, V. Z., Backe, S. J., Bratslavsky, G., & Mollapour, M. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0287 · Cited by 59 · see citing works

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes

Gu, X.-Y., Guan, J., Xu, J., Zheng, Q., Chen, C., Yang, Q., Huang, C., Wang, G., Zhou, H., Chen, Z., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02691-4 · Cited by 38 · see citing works

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma

Song, P., Li, W., Wu, X., Qian, Z., Ying, J., Gao, S., & He, J. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03143-2 · Cited by 54 · see citing works

Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer

Sun, N., Kabir, M., Lee, Y., Xie, L., Hu, X., Velez, J., Chen, X., Kanıskan, H. Ü., & Jin, J. J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01505 · Cited by 43 · see citing works

BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) promotes lung adenocarcinoma by interacting with Zinc Finger Protein ZNF143 and regulating glycolysis

Zhou, X., Yuan, Y., Kuang, H., Bingxiang, T., Zhang, H., & Zhang, M. (2022) · Bioengineered · doi:10.1080/21655979.2021.2013108 · Cited by 36 · see citing works

Prognostic Value of Lactate Dehydrogenase Expression in Different Cancers: A Meta-Analysis

Lv, J., Zhou, Z., Wang, J., Yu, H., Lu, H., Yuan, B., Han, J., Zhou, R., Zhang, X., Yang, X. F., et al. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.09.012 · Cited by 35 · see citing works

Expression of HIF-1α and Genes Involved in Glucose Metabolism Is Increased in Cervical Cancer and HPV-16-Positive Cell Lines

Priego-Hernández, V. D., Arizmendi-Izazaga, A., Soto-Flores, D. G., Santiago-Ramón, N., Feria-Valadez, M. D., Navarro‐Tito, N., Jiménez‐Wences, H., Martínez-Carrillo, D. N., Salmerón-Bárcenas, E. G., Leyva‐Vázquez, M. A., et al. (2022) · Pathogens · doi:10.3390/pathogens12010033 · Cited by 35 · see citing works

Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Zengin, T., & Önal-Süzek, T. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020154 · Cited by 33 · see citing works

A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism

Sheraj, I., Güray, T., & Banerjee, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-93003-3 · Cited by 29 · see citing works

Loss of DSTYK activates Wnt/β-catenin signaling and glycolysis in lung adenocarcinoma

Zhong, C., Chen, M., Chen, Y., Yao, F., & Fang, W. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04385-1 · Cited by 26 · see citing works

Identification of a 5-Gene Metabolic Signature for Predicting Prognosis Based on an Integrated Analysis of Tumor Microenvironment in Lung Adenocarcinoma

Yu, X., Zhang, X., & Zhang, Y. (2020) · Journal of Oncology · doi:10.1155/2020/5310793 · Cited by 22 · see citing works

20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells

Shuvalov, O., Kirdeeva, Y., Fefilova, E., Netsvetay, S., Zorin, M., Vlasova, Y., Fedorova, O., Daks, A., Parfenyev, S., & Barlev, N. (2023) · Metabolites · doi:10.3390/metabo13050656 · Cited by 21 · see citing works

Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer

Thaiparambil, J. T., Dong, J., Grimm, S. L., Perera, D. N., Ambati, C. S. R., Putluri, V., Robertson, M. J., Patel, T. D., Mistretta, B., Gunaratne, P. H., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4933 · Cited by 20 · see citing works

Lactate metabolic checkpoint in immuno-oncology: mechanisms and therapeutic implications

Wang, Z., Gu, Z., Mo, W., & Zhang, H. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218038 · Cited by 19 · see citing works

Development of a gene signature associated with iron metabolism in lung adenocarcinoma

Qin, J., Xu, Z., Deng, K., Qin, F., Wei, J., Yuan, L., Sun, Y., Zheng, T., & Li, S. (2021) · Bioengineered · doi:10.1080/21655979.2021.1954840 · Cited by 16 · see citing works

Salvianolic Acid B Suppresses Non-Small-Cell Lung Cancer Metastasis through PKM2-Independent Metabolic Reprogramming

Zhang, H., Tang, J., Cao, Y. J., & Wang, T. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/9302403 · Cited by 13 · see citing works

Lactate released by lung adenocarcinoma (LUAD) cells promotes M2 macrophage polarization via the GPR132/cAMP/PKA pathway

Chen, X., Zhang, Z., & Wang, K. (2025) · Genes & Genomics · doi:10.1007/s13258-025-01622-1 · Cited by 10 · see citing works

A promising prognostic signature for lung adenocarcinoma (LUAD) patients basing on 6 hypoxia-related genes

Luo, J., & Du, X. (2021) · Medicine · doi:10.1097/md.0000000000028237 · Cited by 10 · see citing works

CENPE and LDHA were potential prognostic biomarkers of chromophobe renal cell carcinoma

Wu, H., Liu, H., Zhang, Z., & Chen, J. (2023) · European journal of medical research · doi:10.1186/s40001-023-01449-0 · Cited by 8 · see citing works

S100a4+ alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting the angiogenic function regulated by fatty acid metabolismPreprint

Huang, H., Yang, Y., Zhang, Q., Yang, Y., Xiong, Z., Mao, S., Song, T., Wang, Y., Liu, Z., Bu, H., et al. (2024) · eLife · doi:10.7554/elife.101731 · Cited by 7 · see citing works

Pyruvate Kinase M2 is a marker of poor prognosis in lung adenocarcinoma but not lung squamous cell carcinoma

Zhang, J., Zhang, C., Liu, X.-H., Sun, N., Zhang, C., Li, R., & Zhang, Z. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.04.23 · Cited by 6 · see citing works

A novel mTOR-associated gene signature for predicting prognosis and evaluating tumor immune microenvironment in lung adenocarcinoma

Zheng, Z. G., Li, Y., Lu, X. L., Zhang, J., Liu, Q., Zhou, D., Deng, X., Qiu, Y., Chen, Q., Zheng, H., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105394 · Cited by 6 · see citing works

Lactate dehydrogenase A is a diagnostic biomarker associated with immune infiltration, m6A modification and ferroptosis in endometrial cancer

Huang, Y. H., Tang, W., & Chen, L. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1458344 · Cited by 5 · see citing works

Prognostic value of a lactate metabolism gene signature in lung adenocarcinoma and its associations with immune checkpoint blockade therapy response

Huang, T., Lian, D., Chen, M., Liu, Y., Zhang, M., Zeng, D., Zhou, S., & Ying, W. (2024) · Medicine · doi:10.1097/md.0000000000039371 · Cited by 5 · see citing works

Guidelines on lung adenocarcinoma prognosis based on immuno-glycolysis-related genes

Zhang, Y., Qin, W., Zhang, W., Qin, Y., & Zhou, Y. L. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-03000-9 · Cited by 5 · see citing works

A Novel Prognostic and Predictive Signature for Lung Adenocarcinoma Derived from Combined Hypoxia and Infiltrating Immune Cell-Related Genes in TCGA Patients

Wu, X., Zhu, J., Liu, W., Jin, M., Xiong, M., & Hu, K. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s342107 · Cited by 4 · see citing works

Construction of a prognostic model based on memory CD4+ T cell–associated genes for lung adenocarcinoma and its applications in immunotherapy

Li, Y., Ye, X., Huang, H., Cao, R., Huang, F., & Chen, L. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13122 · Cited by 4 · see citing works

Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures

Jiang, W., Zhang, F., Tang, Z., Xu, S., Zhang, Y., Liu, L., Zhong, D., & Liu, Y. (2024) · International Journal of Clinical Oncology · doi:10.1007/s10147-024-02664-3 · Cited by 4 · see citing works

Development and validation of a 16-gene T-cell- related prognostic model in non-small cell lung cancer

Zhang, A., Ting, H., Ma, J., Xia, X., Lao, X., Li, S., & Liang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1566597 · Cited by 3 · see citing works

Improvement of Diagnostic Accuracy for Pancreatic Cancer with Serum Lactate Dehydrogenase

Wang, X., Wang, C., & Zhang, H. (2021) · Cancer Management and Research · doi:10.2147/cmar.s312312 · Cited by 3 · see citing works

Unlocking the secrets of glucose metabolism reprogramming: the role in pulmonary diseases

Li, Z., Chen, S.-X., Jiang, S., Yang, Y.-N., & Yan, X.-C. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1551452 · Cited by 2 · see citing works

High FAM83A Expression is a Novel Prognostic Indicator of Poor Overall Survival in Lung Adenocarcinoma

Xie, L., Li, Y., Dang, Y., Cui, C., Chao, X., Guo, Y., & Guo, X. (2019) · International Conference on Information Technology in Medicine and Education · doi:10.1109/itme.2019.00040 · Cited by 2 · see citing works

S100a4+ alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting the angiogenic function regulated by fatty acid metabolism

Huang, H., Yang, Y., Zhang, Q., Yang, Y., Xiong, Z., Mao, S., Song, T., Wang, Y., Liu, Z., Bu, H., et al. (2025) · eLife · doi:10.7554/elife.101731.3 · Cited by 1 · see citing works

A succinylation-related prognostic model for predicting lung adenocarcinoma prognosis and guiding immunotherapy

Li, Z., Liu, Q., Lu, E., Zhang, T., & Zhu, Y. (2026) · Clinical Proteomics · doi:10.1186/s12014-025-09570-4 · Cited by 1 · see citing works

Establishing a Novel Gene Signature Related to Histone Modifications for Predicting Prognosis in Lung Adenocarcinoma

Liu, M., Yu, X., Xu, S., & Qu, C. (2022) · Journal of Oncology · doi:10.1155/2022/8802573 · Cited by 1 · see citing works

Identification of pivotal genes with prognostic evaluation value in lung adenocarcinoma by bioinformatics analysis

Wang, Y., Wang, R., Ma, J., Wang, T., Ma, C., Xu, Y., Xu, Y., & Wang, Y. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.8.34 · Cited by 1 · see citing works

Identification of a Novel Prognostic Lymphangiogenesis‐Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma

Peng, J., Liu, D., Zhang, H., Hu, Q.-H., Chen, W., Zou, J., Zhang, J., Li, H., Gao, A., & Li, Y. (2024) · Analytical Cellular Pathology · doi:10.1155/2024/2090450 · Cited by 1 · see citing works

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma

Wu, M., Wu, Z., Yan, J., Zeng, J., Kuang, J., Zhong, C., Zhu, X., Mo, Y., Guo, Q., Li, D., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1198746 · Cited by 1 · see citing works

S100a4+ alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting fatty acid metabolismPreprint

Huang, H., Yang, Y., Zhang, Q., Yang, Y., Xiong, Z., Mao, S., Song, T., Wang, Y., Liu, Z., Bu, H., et al. (2024) · eLife · doi:10.7554/elife.101731.1 · Cited by 1 · see citing works

A Novel Defined Risk Signature Based on Lactate-Related Genes can Predicts Prognosis of Bladder CancerPreprint

Hu, D., Jin, Y., Li, Z., Huang, W., Cao, Q., Tong, G., Peng, H., Shen, T., Wu, W.-K., Tong, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1387518/v1

A Novel Defined Risk Signature Based on Lactate-Related Genes can Predicts Prognosis of Bladder CancerPreprint

Hu, D., Jin, Y., Li, Z., Huang, W., Cao, Q., Tong, G., Peng, H., Shen, T., Wei-kang, W., Tong, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1387518/v2

Comprehensive Analysis of Molecular Characteristics, Clinical Signifificance, and Cancer Immune Interactions of Patients by Anoikis-Related Genes in LUAD Combined with Single-cell DataPreprint

Yu, W., Miao, Z., Ainiwaer, J., Qiao, B., Jumai, K., & Sheyhidin, I. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.15.540748

Additional file 6 of Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes

Gu, X., Guan, J., Xu, J., Zheng, Q., Chen, C., Yang, Q., Huang, C., Wang, G., Zhou, H., Chen, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13531699

S100a4+ alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting the angiogenic function regulated by fatty acid metabolismPreprint

Huang, H., Yang, Y., Zhang, Q., Yang, Y., Xiong, Z., Mao, S., Song, T., Wang, Y., Liu, Z., Bu, H., et al. (2025) · eLife · doi:10.7554/elife.101731.2

Additional file 5 of Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes

Gu, X., Guan, J., Xu, J., Zheng, Q., Chen, C., Yang, Q., Huang, C., Wang, G., Zhou, H., Chen, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13531696

Additional file 1 of Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes

Gu, X., Guan, J., Xu, J., Zheng, Q., Chen, C., Yang, Q., Huang, C., Wang, G., Zhou, H., Chen, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13531684

Additional file 2 of Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes

Gu, X., Guan, J., Xu, J., Zheng, Q., Chen, C., Yang, Q., Huang, C., Wang, G., Zhou, H., Chen, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13531687

Additional file 3 of Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes

Gu, X., Guan, J., Xu, J., Zheng, Q., Chen, C., Yang, Q., Huang, C., Wang, G., Zhou, H., Chen, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13531690

Additional file 4 of Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes

Gu, X., Guan, J., Xu, J., Zheng, Q., Chen, C., Yang, Q., Huang, C., Wang, G., Zhou, H., Chen, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13531693

BindingDB Entry 50019168: Discovery of the First Lactate Dehydrogenase Proteolysis Targeting Chimera Degrader for the Treatment of Pancreatic Cancer.

BindingDB (2024) · UC San Diego · doi:10.7270/q2f76hvr

Competing Endogenous TMPO-AS1-let-7c-5p- LDHA RNA Network Predicts the Prognosis of Lung Adenocarcinoma Patients

Nema, R., Vats, P., Singh, J., Srivastava, S. K., & Kumar, A. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.10.3673 · Cited by 3 · see citing works

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma

Tan, J., Chen, F., Ouyang, B., Li, X., Zhang, W., & Gao, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.865756 · Cited by 10 · see citing works

Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.

Xu, X.-L., Gong, Y., & Zhao, D.-P. (2018) · PubMed · doi:10.26355/eurrev_201812_16638 · Cited by 13 · see citing works

LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma

Li, L., Feng, T., Qu, J., Feng, N., Wang, Y., Ma, R., Li, X., Zheng, Z., Yu, H., & Qian, B. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2017.0194 · Cited by 14 · see citing works

CDCA gene family promotes progression and prognosis in lung adenocarcinoma

Liu, X., Zhu, X., Zhao, Y., Shan, Y., Gao, Z., & Yuan, K. (2024) · Medicine · doi:10.1097/md.0000000000038581 · Cited by 5 · see citing works